MARINA DOI: Open Payments
NPI 1699478537 · FRESNO, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,095 in 48 payments from 11 companies in 2025. Trend: 2023 $353 · 2024 $782 · 2025 $1,095
Food & beverage: $1,095
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $297 |
| Novo Nordisk Inc | 15 | $287 |
| AstraZeneca Pharmaceuticals LP | 6 | $155 |
| Eisai Inc. | 1 | $122 |
| PFIZER INC. | 3 | $55 |
| VERTEX PHARMACEUTICALS INCORPORATED | 2 | $40 |
| Kowa Pharmaceuticals America, Inc. | 2 | $38 |
| Lilly USA, LLC | 2 | $34 |
| Amgen Inc. | 1 | $24 |
| Phathom Pharmaceuticals, Inc. | 3 | $23 |
Products named: Ozempic, VRAYLAR, Leqembi, AIRSUPRA, FARXIGA, NURTEC ODT, JOURNAVX, ZORYVE.
Industry payments across CA — which companies pay providers there.
